SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-000938
Filing Date
2021-01-04
Accepted
2021-01-04 16:00:58
Documents
3
Period of Report
2021-01-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d100748d8k.htm 8-K 17844
2 EX-99.1 d100748dex991.htm EX-99.1 11762
3 GRAPHIC g100748g0104144412282.jpg GRAPHIC 3174
  Complete submission text file 0001193125-21-000938.txt   35295
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38800 | Film No.: 21501749
SIC: 2836 Biological Products, (No Diagnostic Substances)